Published in Mol Biol Cell on July 11, 2012
Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol (2014) 1.57
MAPK signaling pathway alters expression of midgut ALP and ABCC genes and causes resistance to Bacillus thuringiensis Cry1Ac toxin in diamondback moth. PLoS Genet (2015) 1.00
β1 integrin is a crucial regulator of pancreatic β-cell expansion. Development (2013) 0.97
The membrane-proximal KXGFFKR motif of α-integrin mediates chemoresistance. Mol Cell Biol (2013) 0.81
BAALC potentiates oncogenic ERK pathway through interactions with MEKK1 and KLF4. Leukemia (2015) 0.76
Discoidin domain receptor 1 promotes Th17 cell migration by activating the RhoA/ROCK/MAPK/ERK signaling pathway. Oncotarget (2016) 0.75
Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance. PLoS One (2016) 0.75
Hepatocyte SLAMF3 reduced specifically the multidrugs resistance protein MRP-1 and increases HCC cells sensitization to anti-cancer drugs. Oncotarget (2016) 0.75
Computational design of molecular motors as nanocircuits in Leishmaniasis. F1000Res (2017) 0.75
Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (1992) 8.84
Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res (2000) 4.89
Integrin ligands at a glance. J Cell Sci (2006) 4.76
The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood (2002) 4.02
The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance. Clin Cancer Res (2008) 3.50
Environment-mediated drug resistance: a major contributor to minimal residual disease. Nat Rev Cancer (2009) 3.49
Integrin signalling at a glance. J Cell Sci (2009) 3.28
Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiol Rev (2006) 3.22
Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci U S A (1990) 3.03
Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J Clin Invest (2006) 2.64
Identification of multidrug resistance protein 1 (MRP1/ABCC1) as a molecular gate for cellular export of cobalamin. Blood (2009) 2.49
Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology (2002) 2.38
Signalling via integrins: implications for cell survival and anticancer strategies. Biochim Biophys Acta (2006) 2.18
Integrins and cell-fate determination. J Cell Sci (2009) 1.76
ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. Carcinogenesis (2005) 1.59
Mechanisms of drug resistance in cancer chemotherapy. Med Princ Pract (2005) 1.57
The P-glycoprotein multidrug transporter. Essays Biochem (2011) 1.56
Mechanism of cell adaptation: when and how do cancer cells develop chemoresistance? Cancer J (2011) 1.51
Cytohesin-1 regulates fMLF-mediated activation and functions of the β2 integrin Mac-1 in human neutrophils. J Leukoc Biol (2011) 1.47
Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways. Mol Cells (2004) 1.46
Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases. FEBS J (2011) 1.41
Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res (2002) 1.39
Sp1 phosphorylation by Erk 2 stimulates DNA binding. Biochem Biophys Res Commun (1999) 1.27
ABCG2: the key to chemoresistance in cancer stem cells? Expert Opin Drug Metab Toxicol (2009) 1.26
Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1. Leukemia (2006) 1.24
T cell receptor-dependent, antigen-specific stimulation of a murine T cell clone induces a transient, VLA protein-mediated binding to extracellular matrix. J Immunol (1991) 1.21
ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts. Clin Sci (Lond) (2007) 1.20
Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1. Expert Opin Drug Metab Toxicol (2005) 1.16
Glutathione export during apoptosis requires functional multidrug resistance-associated proteins. J Biol Chem (2007) 1.15
SLCO/OATP-like transport of glutathione in FasL-induced apoptosis: glutathione efflux is coupled to an organic anion exchange and is necessary for the progression of the execution phase of apoptosis. J Biol Chem (2006) 1.14
Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFalpha. Ann Rheum Dis (2004) 1.13
The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1. Oncogene (2006) 1.13
ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia. Clin Cancer Res (2006) 1.11
Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake. Pharm Res (1999) 1.01
Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma. Cancer Res (2009) 1.01
Sensitive and specific fluorescent probes for functional analysis of the three major types of mammalian ABC transporters. PLoS One (2011) 1.01
Engagement of the alpha2beta1 integrin inhibits Fas ligand expression and activation-induced cell death in T cells in a focal adhesion kinase-dependent manner. Blood (2000) 0.99
Integrin alpha2beta1 inhibits Fas-mediated apoptosis in T lymphocytes by protein phosphatase 2A-dependent activation of the MAPK/ERK pathway. J Biol Chem (2003) 0.99
Distribution of breast cancer resistance protein (BCRP/ABCG2) mRNA expression along the human GI tract. Biochem Pharmacol (2005) 0.99
Single-cell STAT5 signal transduction profiling in normal and leukemic stem and progenitor cell populations reveals highly distinct cytokine responses. PLoS One (2009) 0.98
Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells. Proc Natl Acad Sci U S A (2011) 0.98
Selective induction of the Notch ligand Jagged-1 in macrophages by soluble egg antigen from Schistosoma mansoni involves ERK signalling. Immunology (2008) 0.97
Glutathione transferases as targets for cancer therapy. Anticancer Agents Med Chem (2009) 0.96
Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells. J Pharmacol Exp Ther (2004) 0.90
The role of chemokines and extracellular matrix components in the migration of T lymphocytes into three-dimensional substrata. Immunology (2005) 0.89
Two functional active conformations of the integrin {alpha}2{beta}1, depending on activation condition and cell type. J Biol Chem (2005) 0.89
Hypoxia-induced extracellular acidosis increases p-glycoprotein activity and chemoresistance in tumors in vivo via p38 signaling pathway. Adv Exp Med Biol (2011) 0.86
Effect of culture conditions on the expression and function of Bsep, Mrp2, and Mdr1a/b in sandwich-cultured rat hepatocytes. Biochem Pharmacol (2006) 0.86
Multidrug resistance-related protein 1 (MRP1) function and localization depend on cortical actin. Mol Pharmacol (2010) 0.85
Adult T-cell leukemia cells over-express the multidrug-resistance-protein (MRP) and lung-resistance-protein (LRP) genes. Int J Cancer (1999) 0.85
Role of the tumor microenvironment in the activity and expression of the p-glycoprotein in human colon carcinoma cells. Oncol Rep (2007) 0.85
Identification of DNA-protein interactions in the 5' flanking and 5' untranslated regions of the human multidrug resistance protein (MRP1) gene: evaluation of a putative antioxidant response element/AP-1 binding site. Biochem Biophys Res Commun (2001) 0.85
Collagen type I-mediated activation of ERK/MAP Kinase is dependent on Ras, Raf-1 and protein phosphatase 2A in Jurkat T cells. Mol Immunol (2005) 0.85
Cloning and Characterization of the Murine and Rat mrp1 Promoter Regions. Mol Pharmacol (2003) 0.83
HLA-DR signaling inhibits Fas-mediated apoptosis in A375 melanoma cells. Exp Cell Res (2004) 0.82
Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells. Anticancer Res (2007) 0.82
Collagen-mediated survival signaling is modulated by CD45 in Jurkat T cells. Mol Immunol (2007) 0.81
Collagen type I signaling reduces the expression and the function of human receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes. Eur J Immunol (2005) 0.81
The MDR1 (P-glycoprotein) and MRP (P-190) transporters do not play a major role in the intrinsic multiple drug resistance of Jurkat T lymphocytes. Leuk Res (1998) 0.79
Multidrug resistance mechanisms in chronic lymphocytic leukaemia. Br J Haematol (2002) 0.77
Expression of the multidrug resistance-associated protein in myelodysplastic syndromes. Br J Haematol (2000) 0.76
Differential regulation of P-glycoprotein genes in primary rat hepatocytes by collagen sandwich and drugs. J Cell Biochem (2002) 0.76
Protein kinase C-zeta regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-alpha in glioma cells via NF-kappa B. J Biol Chem (2002) 1.32
Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis. Mol Cancer Res (2008) 1.17
Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway. Immunology (2010) 1.15
Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function. PLoS One (2011) 1.07
Integrin alpha2beta1 inhibits Fas-mediated apoptosis in T lymphocytes by protein phosphatase 2A-dependent activation of the MAPK/ERK pathway. J Biol Chem (2003) 0.99
α2β1 integrin promotes chemoresistance against doxorubicin in cancer cells through extracellular signal-regulated kinase (ERK). J Biol Chem (2012) 0.95
MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis. J Immunol (2011) 0.94
Discoidin domain receptor 1 expression in activated T cells is regulated by the ERK MAP kinase signaling pathway. J Cell Biochem (2011) 0.92
Alpha2beta1 integrin is the major collagen-binding integrin expressed on human Th17 cells. Eur J Immunol (2010) 0.89
Alpha2 beta1 integrin signaling augments T cell receptor-dependent production of interferon-gamma in human T cells. Mol Immunol (2007) 0.86
Collagen type I-mediated activation of ERK/MAP Kinase is dependent on Ras, Raf-1 and protein phosphatase 2A in Jurkat T cells. Mol Immunol (2005) 0.85
Implication of discoidin domain receptor 1 in T cell migration in three-dimensional collagen. Mol Immunol (2010) 0.84
Alpha1beta1 integrin and interleukin-7 receptor up-regulate the expression of RANKL in human T cells and enhance their osteoclastogenic function. Immunology (2008) 0.83
Pathologic expression of MHC class II is driven by mitogen-activated protein kinases. Eur J Immunol (2007) 0.83
Crosstalk between T cells and bronchial fibroblasts obtained from asthmatic subjects involves CD40L/alpha 5 beta 1 interaction. Mol Immunol (2010) 0.82
Collagen type I signaling reduces the expression and the function of human receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes. Eur J Immunol (2005) 0.81
α2β1 integrin regulates Th17 cell activity and its neutralization decreases the severity of collagen-induced arthritis. J Immunol (2013) 0.77
P21(Waf1/Cip1) in endothelial cell survival. Cardiovasc Res (2004) 0.75